1382-4376

Russian Journal of Gastroenterology Hepatology Coloproctology

Russian Gastroenterolgocial Society

View prefix report (10.22416)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 158 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact158 DOIs
2

Add abstracts to 125 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact125 DOIs
3

Deposit reference lists for 106 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact106 DOIs

DOIs for this ISSN

Showing the top 5 of 466 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Recommendations of the Russian Gastroenterological Associati… (10.22416/1382-4376-2020-30-4-70-97)
Abstract
51.89 118
2 The role of protective factors disorders of acid-related dis… (10.22416/1382-4376-2016-26-3-115-116)
References ORCID
50.00 9
3 Diagnostics and treatment of non-alcoholic fatty liver disea… (10.22416/1382-4376-2016-26-2-24-42)
ORCID
49.44 94
4 Gallstone disease diagnosis and treatment: guidelines of the… (10.22416/1382-4376-2016-26-3-64-80)
ORCID
44.45 59
5 Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical… (10.22416/1382-4376-2020-30-1-49-70)
Abstract
43.90 56
6 Early Detection of Oncological Diseases of the Digestive Sys… (10.22416/1382-4376-2019-29-5-53-74)
References
40.05 39
7 The resolution of Advisory council «How to improve treatment… (10.22416/1382-4376-2016-26-2-101-104)
References ORCID
38.91 5
8 Diagnostics and treatment of diverticular disease of the col… (10.22416/1382-4376-2016-26-1-65-80)
ORCID
38.60 34
9 An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis… (10.22416/1382-4376-2019-29-6-22-29)
Abstract
36.18 27
10 Noninvasive diagnostic methods of liver fibrosis in patients… (10.22416/1382-4376-2016-26-3-52-63)
Abstract ORCID
34.95 4
11 Возможности применения Опросника «7х7» (7 симптомов за 7 дне… (10.22416/1382-4376-2016-26-3-24-33)
ORCID
30.76 16
12 Treatment compliance of patients with gastro-intestinal dise… (10.22416/1382-4376-2016-26-1-20-28)
Abstract ORCID
30.10 3
13 Hexapeptide dalargin in clinical gastroenterology: 30 years'… (10.22416/1382-4376-2016-26-3-103-112)
ORCID
29.40 14
14 Morbidity and Mortality Rates from Digestive Diseases in the… (10.22416/1382-4376-2019-29-1-36-46)
ORCID
29.40 14
15 Hematological manifestations of autoimmune gastritis (10.22416/1382-4376-2016-26-1-37-43)
ORCID
26.03 10
16 Intestinal Short-Chain Fatty Acids in Patients with Bronchia… (10.22416/1382-4376-2019-29-2-53-59)
ORCID
25.00 9
17 Hepatic encephalopathy: pathogenesis, clinical presentation,… (10.22416/1382-4376-2016-26-1-44-53)
ORCID
23.86 8
18 Nosological aspects of hepatomegaly and splenomegaly at pedi… (10.22416/1382-4376-2016-26-1-54-58)
Abstract ORCID
23.86 2
19 Dose-dependent esomeprasole antisecretory effect: results of… (10.22416/1382-4376-2016-26-3-33-40)
Abstract ORCID
23.86 2
20 Intestinal Barrier, Permeability and Nonspecific Inflammatio… (10.22416/1382-4376-2020-30-4-52-59)
Abstract
23.86 8
21 Rebamipide during chronic gastritis: <i>H. pylori</… (10.22416/1382-4376-2023-33-6-81-87)
Abstract
23.86 8
22 Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Li… (10.22416/1382-4376-2019-29-1-17-23)
ORCID
22.58 7
23 Pathogenetic Aspects of Oral Cavity Lesions in Inflammatory… (10.22416/1382-4376-2019-29-4-15-21)
ORCID
22.58 7
24 Prospects of Using Microbiota Correction Methods in the Trea… (10.22416/1382-4376-2019-29-2-12-22)
ORCID
21.13 6
25 Assessment of Bowel Preparation Using Low-Volume Sulphate-Ba… (10.22416/1382-4376-2019-29-2-60-75)
ORCID
21.13 6
26 Gastroesophageal Reflux Disease and Erosive-Ulcerative Lesio… (10.22416/1382-4376-2019-29-4-22-29)
ORCID
21.13 6
27 Indicators Of Morbidity And Mortality From Diseases of the D… (10.22416/1382-4376-2019-29-4-30-37)
ORCID
21.13 6
28 Possibilities for the Application of Low-Temperature Argon P… (10.22416/1382-4376-2019-29-6-15-21)
Abstract
21.13 6
29 Association between Growth Hormone and Insulin-like Growth F… (10.22416/1382-4376-2020-30-4-44-51)
Abstract
21.13 6
30 Comparative of relation of American, German, French and Russ… (10.22416/1382-4376-2016-26-2-43-49)
ORCID
19.45 5
31 Contemporary Approaches to the Treatment of Gastroesophageal… (10.22416/1382-4376-2019-29-1-7-16)
ORCID
19.45 5
32 New Parameters for Impedance–pH Monitoring in Diagnosing Gas… (10.22416/1382-4376-2019-29-2-35-44)
ORCID
19.45 5
33 Small Intestinal Bacterial Overgrowth Syndrome as a Risk Fac… (10.22416/1382-4376-2019-29-3-38-48)
ORCID
19.45 5
34 Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Ov… (10.22416/1382-4376-2019-29-5-43-48)
ORCID
19.45 5
35 Improvement of Helicobacter pylori eradication efficacy at s… (10.22416/1382-4376-2016-26-2-11-18)
ORCID
17.47 4
36 Gastroesophageal Reflux Disease and Coronary Heart Disease:… (10.22416/1382-4376-2019-29-4-66-73)
ORCID
17.47 4
37 Neuroendocrine Tumour as a Diagnostic and Prognostic Criteri… (10.22416/1382-4376-2019-29-6-49-59)
Abstract
17.47 4
38 The Role of Motility Impairment in the Pathogenesis of Funct… (10.22416/1382-4376-2019-29-6-7-14)
Abstract
17.47 4
39 Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver… (10.22416/1382-4376-2020-30-4-28-34)
Abstract
17.47 4
40 Clinical significance of Helicobacter pylori infection in ir… (10.22416/1382-4376-2016-26-1-29-36)
Abstract ORCID
15.05 1
41 Colonic cytokines for severe ulcerative colitis (10.22416/1382-4376-2016-26-1-93-98)
Abstract ORCID
15.05 1
42 Short-term results of laparoscopic and open complete mesocol… (10.22416/1382-4376-2016-26-1-99-106)
ORCID
15.05 3
43 Microbiome in development of esophageal diseases (10.22416/1382-4376-2016-26-3-11-16)
ORCID
15.05 3
44 Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic… (10.22416/1382-4376-2019-29-1-24-30)
ORCID
15.05 3
45 Correction of Dysbiosis in Diversion Proctitis: Possibilitie… (10.22416/1382-4376-2019-29-6-36-48)
Abstract
15.05 3
46 Probiotics in the Complex Treatment of Various Diseases of t… (10.22416/1382-4376-2020-30-1-42-48)
Abstract
15.05 3
47 Current Views of Torque Teno Virus (TTV) in Liver Diseases (10.22416/1382-4376-2020-30-4-7-22)
Abstract
15.05 3
48 Kyoto global consensus report on<i>Helicobacter pylori… (10.22416/1382-4376-2016-26-1-59-64)
ORCID
11.93 2
49 Probiotics, metabolism and the functional condition of cardi… (10.22416/1382-4376-2016-26-1-8-14)
ORCID
11.93 2
50 Irritable Bowel Syndrome Diagnosis: Should There Be Alertnes… (10.22416/1382-4376-2019-29-2-76-80)
ORCID
11.93 2